| LIN |
Report |
Adj EPS (Q2 2026) |
BEAT |
pred ~$4.53 vs. cons $4.48 |
MEDIUM |
| LIN |
Report |
Revenue (Q2 2026) |
IN-LINE |
pred ~$9.05B vs. cons $9.01B |
MEDIUM |
| LIN |
Report |
Operating Margin (Q2 2026) |
IN-LINE |
pred ~30.3% vs. cons ~30.2% |
MEDIUM |
| LIN |
Guide |
Adj EPS (Q3 2026) |
LOWER |
guide ~$4.50 mid vs. cons $4.54 |
MEDIUM |
| LIN |
Guide |
Adj EPS (FY 2026) |
UNCHANGED |
guide ~$17.80 mid vs. cons $17.86 |
MEDIUM |
| LIN |
Return |
Day-1 residual (stock − beta × S&P 500) |
+0.3% |
— |
MEDIUM |
| LIN |
Return |
5-day cumulative residual |
-1.5% (FADE) |
FADE — Q3/Q4 estimate cuts follow as sell side models off below-consensus Q3 guide; helium color provides partial offset but insufficient to hold the initial lift |
MEDIUM |